机构地区:[1]天津市第二人民医院,天津300192 [2]天津市肝脏疾病研究所,天津300192
出 处:《临床肝胆病杂志》2015年第9期1418-1421,共4页Journal of Clinical Hepatology
基 金:国家"十二五"科技重大专项(2012ZX10005005)
摘 要:目的比较MELD、MELD-Na、i MELD及MESO四种评分系统预测乙型肝炎相关慢加急性肝衰竭(ACLF)患者经过人工肝治疗短期预后的价值。方法选取2007年10月-2013年2月于天津市第二人民医院住院的乙型肝炎相关ACLF患者221例,分为存活组(139例)和死亡组(82例),测量并比较2组的TBil、血清肌酐(Cr)、国际标准化比值(INR)、血清钠(Na+)以及MELD、MELD-Na、i MELD、MESO评分值。计量资料两组间比较采用独立样本Mann-Whitney U检验或t检验,多组间比较采用KruskalWaillis H检验;计数资料组间比较采用χ2检验;受试者工作特征曲线下面积(AUC)比较采用正态Z检验。结果死亡组的年龄、TBil、INR、MELD、MELD-Na、i MELD及MESO评分均高于存活组,血清Na+水平低于存活组,差异均有统计学意义(P值均<0.001)。肝衰竭晚期各评分均明显高于中期和早期(P值均<0.001),肝衰竭中期各评分均高于早期(P值均<0.001)。MELD、MELD-Na、i MELD及MESO评分越高,病死率越高。四种评分的最佳临界值分别为37.989、41.291、55.406和2.693。四种评分系统两两比较差异均无统计学意义(P值均>0.05)。结论四种评分系统均能较好地预测乙型肝炎相关ACLF患者经过人工肝联合内科综合治疗后短期临床预后,相比之下,i MELD评分略占优势,但应用时仍应密切结合临床实际情况。Objective To investigate the predictive values of four scoring systems, the Model for End - Stage Liver Disease ( MEI J) ), the MELD with incorporation of serum sodium (MELD -Na), the integrated MELD (iMELD), and the MELD to serum sodium ratio ( MESO), in the short -term prognosis of patients with hepatitis B -associated acute -on -chronic liver failure (ACLF) alter artificial liver support therapy. Methods A total of 221 patients with hepatitis B -associated ACLF who were hospitalized from October 2007 to February 2013 were erl- rolled as subjects and divided into survival group (n = 139) and death group (n = 82). The levels of total bilirubin (TBil), serum creatirfirle (Cr) , international normalized ratio (INR) , serum sodium (Na + ) , and the scores of MELD, MELD -Na, iMELD, and MESO were determined and compared between the two groups. Comparison of continuous data between two groups was made by the Mann - Whitney I/test or t test; comparison between multiple groups was made by the Kruskal -Wallis H test; comparison of categorical data was made byx2 test; cornparison of area under the receiver operating characteristic curve was made by normal Z test. Results The age, TBil level, INR, and the scores of MELD, MELD - Na, iMELD, and MESO were significantly higher in the death group than in the survival group, while the serum level of Na + was significantly lower in the death group than in the survival group ( P 〈 0. 001 ). Patients with end - stage liver failure had significantly higher scores than those with early - stage or intermediate - stage liver failure ( P 〈 0.001 ), while patients with intermediate - stage liver failure had significantly higher scores than those with early - stage liver failure ( P 〈 0.001 ). The mortality rate increased with increasing scores of MELD, MELD - Na, iMELD, and MESO. The optimal cut - off scores of MELD, MELD - Na, iMELD, and MESO were 37. 989, 41. 291 , 55. 406, and 2. 693, respectively. There were no signi
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...